More Articles

Access and Evidence

Prescription drug pricing: The times they are a changin’

Ulrich Neumann, (Nov 25, 2019)

The political mood in the US on drug pricing at a national and state level is putting the pressure on pharma to demonstrate value
Commercial

Has direct to consumer marketing in pharma had its day?

Lucy Fulford, (Nov 25, 2019)

Outmoded and cliched DTC campaigns may be harming not helping pharma in the US
Clinical

Clinical must think outside, and inside the box

Paul Simms, (Nov 21, 2019)

From site-in-a-box to virtual/siteless trials: which new model will successfully disrupt clinical research?
Multichannel

The online health trends pharma should be tapping into

Andrew Stone, (Nov 20, 2019)

Pharma should be harnessing some powerful online trends but is it?
Medical

Taking the plunge into digital

Andrew Stone, (Nov 13, 2019)

Medical affairs is starting to expand its knowledge, reach and engagement with digital tools
Access and Evidence

Putting a price on life: Is the answer outside pharma?

Nicola Davies, (Nov 4, 2019)

Gene replacement and cell-based therapies are here to cure, but are we ready for them? The current difficulty pricing groundbreaking healthcare advancements suggests maybe not.
Commercial

Breaking out of data silos in commercial

Ulrich Neumann, (Oct 21, 2019)

Pharma’s commercial teams have much to gain if they can overcome technical and cultural blockages that prevent data sharing
Patients and Medical

Empowering patients with the right data at the right time

Andrew Stone, (Oct 17, 2019)

Pharma is starting to exploit the potential of data from connected devices and smartphones to help patients better manage their conditions
Patients and Medical

Five shifts toward consumer-centric transformation

Jeff Gourdji, (Oct 14, 2019)

There's now a roadmap for pharma organisations seeking to become truly patient centred
Patients and Medical

Putting patients front and center

Andrew Stone, (Sep 20, 2019)

When it comes to access, pharma can only gain by starting with the patient, says Takeda’s Liz Lewis

Pages